Log-in / Create Account  
 
DIA 2013 49th Annual Meeting
Click here to go to the previous page
Electronic Regulatory Submission (ERS) Development and the Impact on the Sponsor's Organization: Retooling R&D for ERS
Track : Track 08:Regulatory Affairs and Submissions
Program Code: 373
Date: Wednesday, June 26, 2013
Time: 4:00 PM to 5:30 PM  EST
Location: 253B
CHAIR :
 Peter M. Lassoff, PharmD (SCHNON), Vice President and Head of Global Regulatory Affairs, Quintiles, Inc., United Kingdom
SPEAKER (S):
Peter M. Lassoff, PharmD (SPKNON), Vice President and Head of Global Regulatory Affairs, Quintiles, Inc., United Kingdom
Murali Chandrashekar, MBA (SPKNON), Sanofi, United States
 Jeffrey S. Morrison, MS (SPKNON), Director, Global Regulatory Operations, GlaxoSmithKline, United States
Description
This session will assist pharmaceutical companies in reorganizing their R&D departments to fit the requirements of electronic regulatory submission development. This will speed up the writing and submission of eCTDs and other electronic submissions leading to faster time to market.

Session Recording
(Code: 373)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON4 Comp Access: Wednesday Online Access Package - June 26, 2013
Handout Online
(Code: 373)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON4 Comp Access: Wednesday Online Access Package - June 26, 2013
Electronic Regulatory Submission (ERS) Development and the Impact on the Sponsor's Organization: Retooling R&D for ERS